AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -18.2% | 8,823 | +68.4% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | +69.2% | 5,239 | +95.4% | 0.00% | – |
| Q4 2021 | $13,000 | -18.8% | 2,681 | -11.2% | 0.00% | -100.0% |
| Q3 2021 | $16,000 | +33.3% | 3,018 | +28.0% | 0.00% | – |
| Q2 2021 | $12,000 | -47.8% | 2,357 | -29.9% | 0.00% | -100.0% |
| Q1 2021 | $23,000 | -14.8% | 3,363 | -51.7% | 0.00% | -66.7% |
| Q3 2020 | $27,000 | -63.0% | 6,961 | -66.8% | 0.00% | -90.6% |
| Q1 2020 | $73,000 | +43.1% | 20,975 | +196.0% | 0.03% | +128.6% |
| Q2 2019 | $51,000 | -60.5% | 7,085 | -22.1% | 0.01% | -72.5% |
| Q1 2019 | $129,000 | -13.4% | 9,097 | -17.2% | 0.05% | -27.1% |
| Q4 2018 | $149,000 | +2880.0% | 10,988 | +4940.4% | 0.07% | +3400.0% |
| Q3 2018 | $5,000 | -90.9% | 218 | -93.5% | 0.00% | -89.5% |
| Q2 2018 | $55,000 | – | 3,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |